Day One Biopharmaceuticals Posts Triple-Digit Revenue Growth Driven by Cancer Drug Success

Brisbane, Sunday, 11 January 2026.
Preliminary data reveals a 172% revenue surge for Day One’s cancer therapy, setting a bullish foundation for projected 2026 sales topping $225 million.